News Focus
News Focus
icon url

Roman516

10/14/22 9:05 PM

#522011 RE: HyGro #522004

NWBO stock has gone up 215% since 2019 whereas NVCR has remained flat at 0% since 2019. The good news is that NWBO should even go even higher in the coming months.
icon url

biosectinvestor

10/15/22 3:54 PM

#522172 RE: HyGro #522004

They did not release TLD. Point me to the press release of TLD stating their results? It is still embargoed. Third-party doctors released some key details at a few scientific conferences. Meanwhile, while markets have collapsed YTD, for speculative companies, this stock has remained relatively flat, with normal fluctuation, a difficult feat for a tiny company stock like this but for confidence in the outcome by the most well informed investors.
icon url

harvest1

10/15/22 4:04 PM

#522176 RE: HyGro #522004

thanks Hygro! Lets all buy NVCR then! Really appreciate the great insights you are providing to the board buddy!
icon url

Roman516

10/15/22 10:06 PM

#522214 RE: HyGro #522004

Since 2019, NWBO has risen 250%
"But yet the NWBO stock has gone NOWHERE since the release of the TLD data. NVCR has been very positive for it's shareholders since it's first Phase 3 GBM trial data was released. Even with the recent decline it is still been very lucrative if you were holding before the 1st Phase trial results were released. NWBO sure can't say that regardless of their exchange." this is bogus news but, NVCR has dropped 40%.